Oncology

[News] Carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate | ClinicLens

In June, 2026, a Working Group of 23 scientists from 13 countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of butyl benzyl phthalate (BBzP), dibutyl phthalate (DBP), and diisononyl phthalate

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.